The CTRC-AACR San Antonio Breast Cancer Symposium features the latest findings in laboratory, translational and clinical breast cancer research. This year's meeting focuses on new and promising therapeutic approaches, as well as strides being made in diagnosing and preventing breast cancer.
A study published in the journal Clinical Cancer Research, a journal of the American Association for Cancer Research, validates a non-invasive screening method with future potential for detection of human papillomavirus (HPV)-positive head and neck cancers.
Women who experience severe gestational hypertension may give birth to boys at lower risk for testicular cancer, although the exact reasons why are still unclear, according to a paper published in the November 1, 2008, issue of Cancer Research, a journal of the American Association for Cancer Research.
Frank L. Meyskens, Jr., M.D., one of the "fathers" of the field of cancer chemoprevention, has been selected to receive the seventh annual American Association for Cancer Research (AACR)-Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research.
The American Association for Cancer Research, in partnership with the Kirk A. and Dorothy P. Landon Foundation, is accepting applications for grants supporting innovation in cancer prevention research and international collaboration. The deadline for applications is November 20, 2008. The grant terms will begin on July 1, 2009.
The American Association for Cancer Research is accepting applications for grants supporting pancreatic cancer research. The deadline for applications is November 10, 2008. The grant terms will begin on July 1, 2009.
A study published in Cancer Research, a journal of the American Association for Cancer Research, suggests a possible role for nicotine in breast tumor development and metastases.
Moderate consumption of red wine may decrease the risk of lung cancer in men, according to a report in the October issue of Cancer Epidemiology, Biomarkers and Prevention¸ a journal of the American Association for Cancer Research.
To stop cancer before it has a chance to take root and spread, scientists are increasingly turning their attention to new discoveries in cancer prevention. Leading experts from around the globe are gathering to share the latest research in this expanding and promising new field, with the hope this work will significantly reduce cancer incidence and mortality.
Some bacteria may help protect against the development of a type of esophageal cancer, known as adenocarcinoma, according to a new review of the medical literature. These bacteria, which are called Helicobacter pylori, live in the stomachs of humans.
In pre-clinical studies, vitamin C appears to substantially reduce the effectiveness of anticancer drugs, say researchers at Memorial Sloan-Kettering Cancer Center.
Clinicians could detect oral squamous cell carcinoma, a form of oral cancer, using a simple test that detects proteins in saliva, according to a report in the October 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research. This work was led by David T. Wong, D.M.D., D.M.Sc., professor and associate dean for research, at the University of California, Los Angeles School of Dentistry.
A new study analyzing gene expression among patients with glioblastomas has found that not all of the common, deadly brain tumors appear the same upon closer examination.
PHILADELPHIA -- Researchers in Hong Kong report that testing patient blood for DNA from Epstein-Barr virus (EBV) during treatment for nasopharyngeal carcinoma effectively predicts clinical outcome. A biomarker test like this, when perfected, could identify patients whose treatment could be intensified after a month or so of standard therapy as well as those who might benefit from lighter treatment.
Activation of the Src signaling pathway may cause resistance to standard medical treatment in some patients with breast cancer, and inhibition of this pathway holds the potential to overcome that resistance, according to data presented here at the American Association for Cancer Research Molecular Diagnostics in Cancer Therapeutic Development meeting.
Researchers have demonstrated a new instrument that makes it possible to detect and quantify multiple different clinically important proteins in a single tumor sample using conventional staining. Currently, pathologists usually need a separate tissue slice for each protein they want to examine, making it impossible to see how molecules interact within individual cells.
Researchers have identified TEM1 as a specific genetic marker for the vascular cells associated with tumor growth, a finding that could aid in diagnosis and treatment of ovarian cancer.
Researchers at The Johns Hopkins University School of Medicine in Baltimore have developed a novel test to screen for chemical modifications to DNA known as methylation. The technology potentially could be used both for early cancer diagnoses and for assessing patients' response to cancer therapies.
As part of its third International Conference on Molecular Diagnostics in Cancer Therapeutic Development, the AACR will host a media roundtable, "Molecular Diagnostics: Leading the World from Philadelphia," featuring three prominent area researchers.
Scientists and clinicians from around the world will gather in Philadelphia, Pennsylvania, next week at the American Association for Cancer Research's third International Conference on Molecular Diagnostics in Therapeutic Development.
Researchers at Wayne State University have tested a breast cancer vaccine they say completely eliminated HER2-positive tumors in mice - even cancers resistant to current anti-HER2 therapy - without any toxicity.
Although cancer remains a leading cause of death in America, it can take up to 12 years to bring a new anti-cancer agent before the FDA and the success rate for approval is only five to 10 percent. That means many research hours and dollars are wasted chasing avenues that will not bring fruit.
The American Association for Cancer Research and The Wellness Community are collaborating to combine their respective scientific integrity and extensive educational resources to reach out to cancer patients, survivors, and their loved ones.
Scientists at the M.D. Anderson Cancer Center have developed a risk prediction assessment for lung cancer specifically for African Americans that suggests a greater risk from chronic obstructive pulmonary disease (COPD), according to a report published in the September issue of Cancer Prevention Research, a journal of the American Association for Cancer Research.
The CTRC-AACR San Antonio Breast Cancer Symposium features the latest cutting-edge findings in laboratory, translational and clinical breast cancer research. This year's meeting focuses on new and promising therapeutic approaches, as well as strides being made in diagnosing and preventing breast cancer.
A man's height is a modest marker for risk of prostate cancer development, but is more strongly linked to progression of the cancer, say British researchers who conducted their own study on the connection and also reviewed 58 published studies.
Radiation from the atomic bomb blasts in Hiroshima and Nagasaki, Japan, in 1945, likely rearranged chromosomes in some survivors who later developed papillary thyroid cancer as adults, according to Japanese researchers.
The American Association for Cancer Research announces the appointment of Timothy Rebbeck, Ph.D., of the University of Pennsylvania, as the Editor-in-Chief of its highly reputed oncology journal Cancer Epidemiology, Biomarkers & Prevention. At the University of Pennsylvania, Rebbeck is the director of both the Center for Genetics and Complex Traits and the Center for Population and Health Disparities. He is also the Associate Director for Population Science at the Abramson Cancer Center and professor of epidemiology.
The AACR Molecular Diagnostics in Cancer Therapeutics Development Meeting features the latest findings in laboratory, translational and clinical cancer research. This year's meeting focuses on new biologic markers and imaging methods.
A combination of chemotherapy agents that have been tested in other tumor types appears to be a promising alternative to standard treatment for advanced non-small cell lung cancer, according to a report in the August 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.
The American Association for Cancer Research (AACR) is currently accepting nominations for the prestigious Pezcoller Foundation"“AACR International Award for Cancer Research.
The American Association for Cancer Research (AACR) is currently accepting nominations for two of the world's most prestigious awards granted to cancer researchers from a professional society of their peers.
Minority men and women who perceived discrimination from their health care providers were less likely to be screened for colorectal or breast cancer, according to a report in the August issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.
PHILADELPHIA "“ Researchers in Germany have discovered that methadone, an agent used to break addiction to opioid drugs, has surprising killing power against leukemia cells, including treatment resistant forms of the cancer.
Based on a pilot study in children with sarcoma, researchers at the National Institutes of Health (NIH) believe that immunotherapy could prove beneficial in treating high-risk forms of this cancer.
The Board of Directors of the American Association for Cancer Research recently elected Beverly W. Aisenbrey and Tyler Jacks, Ph.D., as trustees of the AACR Foundation for the Prevention and Cure of Cancer (AACR Foundation). Elected at the 2008 AACR Annual Meeting, each will serve a term of three years and may be re-elected.
Researchers have determined a novel mechanism through which organ transplantation often leads to cancer, and their findings suggest that targeted therapies may reduce or prevent that risk.
As the scientific partner to Stand Up To Cancer (SU2C), an unprecedented collaboration uniting the major television networks, entertainment industry executives, celebrities and prominent leaders in cancer research and patient advocacy, the American Association for Cancer Research (AACR) issues to the cancer community a call for ideas for translational cancer research projects that hold the most promise for rapid translation into clinical realities.
Although colorectal cancer screening tests are proven to reduce colorectal cancer mortality, only about half of U.S. men and women 50 and older receive the recommended tests, according to a report in the July 2008 issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.
Among patients with castration-resistant prostate cancer, the addition of hormone therapy following vaccine treatment improved overall survival compared with either treatment alone or when the vaccine followed hormone treatment, according to recent data published in the July 15 Clinical Cancer Research, a journal of the American Association for Cancer Research.
The American Association for Cancer Research (AACR) is currently accepting applications for grants designed to help drive research advances in the treatment of bladder cancer, the fourth most commonly diagnosed cancer in men and the eighth in women.
Early laboratory research has shown that resveratrol, a common dietary supplement, suppresses the abnormal cell formation that leads to most types of breast cancer, suggesting a potential role for the agent in breast cancer prevention.
American Association for Cancer Research (AACR) Chief Executive Officer Margaret Foti, Ph.D., M.D. (h.c.) will receive a degree Honoris Causa (h.c.) in Medicine and Surgery from the University of Catania in Sicily on Friday, July 4, 2008. This honorary doctorate is Foti's second and recognizes her distinguished contributions to advancing the field of cancer research worldwide.
The American Association for Cancer Research (AACR) announces the appointment of Diane Scott-Lichter as publisher and head of its scientific publishing division. Scott-Lichter succeeds former publisher Kathleen Case who recently retired following a distinguished seven-year tenure at AACR.
Through the generous philanthropic support of the Littlefield 2000 Trust, the American Association for Cancer Research (AACR) is pleased to announce three recipients of the 2008 Jeannik M. Littlefield-AACR Grants for Metastatic Colon Cancer Research, totaling $1.8 million. In its third year, this competitive funding program is focused on high impact grants to accelerate the discovery and development of new treatments for metastatic colon cancer.
People who have never smoked but whose cells cannot efficiently repair environmental insults to DNA are at higher risk of developing lung cancer than those with effective genomic repair capability, according to researchers from the Department of Epidemiology at The University of Texas M. D. Anderson Cancer Center.
A simple blood test screening for a panel of biomarkers can accurately predict whether a patient who has had prostate cancer surgery will have a recurrence or spread of the disease.
New research suggests that the form of tomato product one eats could be the key to unlocking its prostate cancer-fighting potential, according to a report in the June 1 issue of Cancer Research, a journal of the American Association for Cancer Research.
Stand Up To Cancer (www.standup2cancer.org), a new initiative to raise philanthropic dollars for accelerating ground-breaking research, launches today through an unprecedented collaboration uniting the major television networks, entertainment industry executives, celebrities and prominent leaders in cancer research and patient advocacy.
A comprehensive re-evaluation of the largest prostate cancer prevention study ever completed produced new findings suggesting that men and their doctors should consider a more aggressive approach that includes finasteride to prevent the development of prostate cancer.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right